Evidence map›Paper›PMID 41663395›Full record

ArticleNature communications2026

Multicountry genomic analysis underscores regional cholera spread in Africa.

Gerald Mboowa, Nathaniel Lucero Matteson, Collins Kipngetich Tanui, Mpanga Kasonde, Guyguy Kusanzangana Kamwiziku, Olusola Anuoluwapo Akanbi, Jucunú Johane Elias Chitio, Mathews Kagoli, René Ghislain Essomba, Alisen Ayitewala and 44 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cholera due to exposure in Europe associated with consumption of holy water from Ethiopia, January to February 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors.

Gerald Mboowa *Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.ORCID 0000-0001-8445-9414
Nathaniel Lucero Matteson *Division of Infectious Diseases, Brigham and Women's Hospital, Boston, USA.
Collins Kipngetich Tanui *Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
Mpanga KasondeZambia National Public Health Institute, Lusaka, Zambia.
Guyguy Kusanzangana KamwizikuDepartment of Medical Biology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0000-0001-6770-3999
Olusola Anuoluwapo AkanbiNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.ORCID 0000-0002-1107-035X
Jucunú Johane Elias ChitioInstituto Nacional de Saúde, Marracuene, Mozambique.
Mathews KagoliPublic Health Institute of Malawi, Lilongwe, Malawi.
René Ghislain EssombaNational Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon.
Alisen AyitewalaNational Health Laboratory & Diagnostic Services (NHLDS/CPHL), Ministry of Health, Kampala, Uganda.
Isaac SsewanyanaNational Health Laboratory & Diagnostic Services (NHLDS/CPHL), Ministry of Health, Kampala, Uganda.
Valentina Josiane Ngo BitounguiNational Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon.ORCID 0000-0002-2845-8879
Adrienne Aziza AmuriInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.ORCID 0000-0002-5516-0779
Andrew S AzmanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.ORCID 0000-0001-8662-9077
Olajumoke Atinuke BabatundeNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Blaise Mboringong AkenjiNational Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon.
Anaïs BrobanEpicentre, Paris, France.ORCID 0000-0003-0275-161X
Espoir Bwenge MalembakaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
Francis OngoleNational Health Laboratory & Diagnostic Services (NHLDS/CPHL), Ministry of Health, Kampala, Uganda.
Chimaobi Emmanuel ChukwuNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.ORCID 0000-0003-2411-0290
Nália IsmaelInstituto Nacional de Saúde, Marracuene, Mozambique.
Otridah KaponaZambia National Public Health Institute, Lusaka, Zambia.
Osvaldo LaurindoInstituto Nacional de Saúde, Marracuene, Mozambique.
Placide Kingebeni MbalaDepartment of Medical Biology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0000-0003-1556-3570
Georges Alain Etoundi MballaDepartment for the Control of Diseases, Epidemics and Pandemics, Ministry of Public Health, Yaoundé, Cameroon.
Imelda Carlos Zulfa MiamboInstituto Nacional de Saúde, Marracuene, Mozambique.
Alex Ansaye MwanyongoPublic Health Institute of Malawi, Lilongwe, Malawi.
Grace NajjukaNational Health Laboratory & Diagnostic Services (NHLDS/CPHL), Ministry of Health, Kampala, Uganda.
Joseph MutaleZambia National Public Health Institute, Lusaka, Zambia.
Kunda MusondaZambia National Public Health Institute, Lusaka, Zambia.
Allan Muruta NiyonzimaIntegrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda.
Mirriam Ethel NyenjePublic Health Institute of Malawi, Lilongwe, Malawi.
Michael PopoolaNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Doreen Mainza ShempelaChurches Health Association of Zambia, Lusaka, Zambia.
Christiane Medi SikeFaculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaoundé, Cameroon.
Sofião Manjor SitoeInstituto Nacional de Saúde, Marracuene, Mozambique.
Dorcas Waruguru WanjohiAfrica Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
Placide Okitayemba WeloNational Program of Elimination of Cholera, Ministry of Health, Kinshasa, Democratic Republic of the Congo.
Mtisunge YelewaPublic Health Institute of Malawi, Lilongwe, Malawi.
Sebastian YennanNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Lucius ZibaPublic Health Institute of Malawi, Lilongwe, Malawi.
CholGEN Consortium
Joseph Ephram Bitilinyu-BangohPublic Health Institute of Malawi, Lilongwe, Malawi.
Roma ChilengiZambia National Public Health Institute, Lusaka, Zambia.ORCID 0000-0003-0221-9527
Hamsatou HadjaNational Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon.
Jide IdrisNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
José Paulo Maurício LangaInstituto Nacional de Saúde, Marracuene, Mozambique.
Daniel Mukadi-BamulekaRodolphe Merieux Laboratory INRB-Goma, Goma, Democratic Republic of the Congo.ORCID 0000-0002-6836-8704
Susan NabaddaNational Health Laboratory & Diagnostic Services (NHLDS/CPHL), Ministry of Health, Kampala, Uganda.
Amanda K DebesDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
David A SackDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.ORCID 0000-0002-9338-5119
Yenew Kebede TebejeAfrica Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
Shirlee WohlDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, USA. swohl@bwh.harvard.edu.ORCID 0000-0002-0311-3348
Sofonias Kifle TessemaAfrica Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. SofoniasT@africacdc.org.ORCID 0000-0003-1057-5310

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV-047156
6 · The paper itself

Abstract

Cholera remains a significant public health burden in many countries in sub-Saharan Africa, though the exact mechanisms of bacterial emergence and spread remain largely undefined. We generated genomic data from 763 Vibrio cholerae O1 isolates predominantly collected between 2019-2024 to create the largest dataset of V. cholerae genomes sequenced locally in Africa. This dataset enabled us to interrogate recent patterns of spread, including the rapid circulation of the AFR15 lineage associated with unusually large outbreaks in Southern Africa. We provide evidence for the movement of the AFR15 lineage into new African Union Member States and confirm previously observed differences in V. cholerae transmission dynamics in West versus East Africa, though cross-border transmission is prevalent on both sides of the continent. Despite observed differences, evolutionary processes are similar across lineages and we find no evidence for significant changes in antimicrobial resistance genotypes. Overall, our findings emphasize the importance of regionally coordinated cross-border surveillance and interventions, while also demonstrating the critical role of locally generated genomic data in understanding the spread of cholera in Africa.

Indexed as

CholeraGenome, BacterialVibrio cholerae O1AfricaDisease OutbreaksDrug Resistance, BacterialGenomicsGenotypeHumansPhylogenyVibrio cholerae

Identifiers

PMID41663395
PMCPMC13000271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.